APA

Scagliotti G. V., Gaafar R., Nowak A. K., Nakano T., van Meerbeeck J., Popat S., Vogelzang N. J., Grosso F., Aboelhassan R., Jakopovic M., Ceresoli G. L., Taylor P., Orlandi F., Fennell D. A., Novello S., Scherpereel A., Kuribayashi K., Cedres S., Sørensen J. B., Pavlakis N., Reck M., Velema D., von Wangenheim U., Kim M., Barrueco J. & Tsao A. S. (20200422). Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial. : The Lancet. Respiratory medicine.

Chicago

Scagliotti Giorgio V, Gaafar Rabab, Nowak Anna K, Nakano Takashi, van Meerbeeck Jan, Popat Sanjay, Vogelzang Nicholas J, Grosso Federica, Aboelhassan Rasha, Jakopovic Marko, Ceresoli Giovanni L, Taylor Paul, Orlandi Francisco, Fennell Dean A, Novello Silvia, Scherpereel Arnaud, Kuribayashi Kozo, Cedres Susana, Sørensen Jens Benn, Pavlakis Nick, Reck Martin, Velema Derek, von Wangenheim Ute, Kim Miyoung, Barrueco José and Tsao Anne S. 20200422. Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial. : The Lancet. Respiratory medicine.

Harvard

Scagliotti G. V., Gaafar R., Nowak A. K., Nakano T., van Meerbeeck J., Popat S., Vogelzang N. J., Grosso F., Aboelhassan R., Jakopovic M., Ceresoli G. L., Taylor P., Orlandi F., Fennell D. A., Novello S., Scherpereel A., Kuribayashi K., Cedres S., Sørensen J. B., Pavlakis N., Reck M., Velema D., von Wangenheim U., Kim M., Barrueco J. and Tsao A. S. (20200422). Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial. : The Lancet. Respiratory medicine.

MLA

Scagliotti Giorgio V, Gaafar Rabab, Nowak Anna K, Nakano Takashi, van Meerbeeck Jan, Popat Sanjay, Vogelzang Nicholas J, Grosso Federica, Aboelhassan Rasha, Jakopovic Marko, Ceresoli Giovanni L, Taylor Paul, Orlandi Francisco, Fennell Dean A, Novello Silvia, Scherpereel Arnaud, Kuribayashi Kozo, Cedres Susana, Sørensen Jens Benn, Pavlakis Nick, Reck Martin, Velema Derek, von Wangenheim Ute, Kim Miyoung, Barrueco José and Tsao Anne S. Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial. : The Lancet. Respiratory medicine. 20200422.